Why 1% Is Not Always Stronger Than 0.1%: Topical Steroid Potency Explained

DOCTOR'S NOTES · ECZEMA EVIDENCE

Two tubes of prescribed skin medicine may show different percentages. A larger number is not enough to decide which topical corticosteroid is stronger. The active drug, its chemical form and its vehicle all affect how the medicine performs.

Concentration and potency are different

Concentration describes the amount of a particular ingredient in a formulation. Potency is an assessment of the product's effect. Comparing percentages across different steroid molecules can be misleading, and a cream and an ointment containing the same drug may differ in how they deliver it. A review of topical steroid vehicles discusses how the base affects availability and skin effects.

Avoid swapping tubes by appearance

Skin thickness varies by body site; a medicine selected for one part of the body may not be appropriate for the eyelids or skin folds. Ask before applying under an occlusive wrap. Do not substitute, increase or extend a prescription based on the percentage on another tube. A pharmacist can help identify a product when labels look alike. The AAD adult topical-treatment guideline discusses the place of topical corticosteroids in eczema care.

For amounts, read what a fingertip unit means. For safety concerns, see the discussion of topical steroid withdrawal.

Build a medicine list that someone else can follow

For a baby or an adult with several affected areas, request a written map naming the medicine, body site and review point. Include the complete name and formulation rather than “the strong tube” or “the blue cream.” Those nicknames can become confusing when a pharmacy dispenses a different package. Keep original labels and ask a pharmacist to resolve uncertainty before using an unfamiliar tube.

The number on a label can be useful when comparing concentrations of the same drug in defined formulations, but it should not be used as a universal strength scale across unrelated medicines. A nonsteroidal eczema medicine with a larger percentage is not automatically stronger than a topical steroid with a smaller percentage, either.

Ask how success and problems will be reviewed

Clarify what improvement to expect and when to call if it does not happen. A poor response can prompt a review of the diagnosis, amount, access, technique or contact exposures; it is not an instruction to keep escalating potency yourself. Tell the prescriber if burning, a new rash or an unexpected change follows application. With children, ask for age-specific instructions and never borrow another family member's prescription.

Use one source of instructions across caregivers

When more than one adult applies a child's medicine, agree on a single current written plan. If the clinician changes a preparation, update the list rather than leaving two competing instructions in circulation. Ask how to identify medicines that are no longer part of the plan and how to store them safely. Similar-looking tubes and different percentages are common sources of confusion; a brief check with the pharmacist can clarify identity before application. Do not use a leftover prescription on a new rash simply because the earlier rash was called eczema.

Follow the related evidence

An infant study does not automatically expand a label; the PETITE pimecrolimus article explains that distinction. The oral-steroid discussion addresses another route with a different evidence and risk profile.

Prepared by the Dr. Arsy editorial team. Sources checked November 8, 2026. Educational information supports a discussion with a qualified clinician; it does not diagnose or prescribe for an individual. The AI-created product image is an editorial illustration, not a patient photograph or a clinical result.